The 6th Asian Pharmacometrics Network Annual Workshop and Symposium 2024

18 – 20 November 2024

To celebrate its 78th anniversary, the Faculty of Pharmacy Universitas Gadjah Mada, Yogyakarta, Indonesia in collaboration with the Asian Pharmacometrics Network (APN), will organize the 6th APN Annual Workshop and Symposium 2024.

The theme of the event is “Pharmacometrics in the Optimization of Drug Development and Clinical Therapy”. The event will consist of a pre-symposium workshop and the main symposium.

Registration is free of charge for workshop, symposium and both events!

Registration is opened until 15 November 2024 at 23.59 Jakarta time (GMT +7).

 A. APN 2024 Pre-symposium Workshop

“Handling Pharmacometrics Case Study in the Optimization of Drug  Development and Clinical Therapy”

 

Time (GMT +7, Jakarta time) Agenda Speaker
08.00 – 08.15 Opening speech by Dean Faculty of Pharmacy UGM Prof. Dr. Satibi (Dean FF UGM)
08.15 – 08.45 Introduction of Case I and II Prof. Dr. Surulivelrajan Mallayasamy
08.45 – 09.00 Break
09.00 – 09.30 Software Tutorial Prof. Akhmad Kharis Nugroho
10.00 – 12.00 Group Assignment and Discussion Prof. Dr. Surulivelrajan Mallayasamy

Prof Kharis

12.00 – 13.00 Break
13.00 – 14.00 Presentation of Case I Prof. Dr. Surulivelrajan Mallayasamy
14.00 – 15.00 Presentation of Case II Prof. Akhmad Kharis Nugroho
15.00 – 15.30 Concluding remark of APN Workshop Prof. Dr. Surulivelrajan Mallayasamy

Prof. Akhmad Kharis Nugroho

B. The 6th APN Annual Workshop and Symposium 2024

Day 1: Tuesday, 19 November 2024

Time (GMT +7, Jakarta time) Agenda Speaker
08.00 – 08.15 Opening speech by Dean Faculty of Pharmacy UGM Prof. Dr. Satibi (Dean FF UGM)
08.15 – 08.30 Opening remark of APN 2024 Symposium Prof. Kyungsoo Park
08.30 – 09.45 Keynote Lecture Day 1:

Update in ICH-15 on the strategic role of Pharmacometrics in Accelerating MIDD

Dr. Jenny Chien

Panelists:

a. Dr. Daisuke Iwata

b. Dr. Norisuke Kawai

c. Kennya Nakai

09.45 – 10.00 Break
10.00 – 12.00 APN lectures session 1 1. Dr. Rujia Xie

2. Prof. Chen Zhao

3. Prof. Eun Kyoung (“Christina”) Chung, PharmD, PhD

4. So Jin Lee, Pharm.D., Ph.D.

12.00 – 13.00 Break
13.00 – 14.00 Student contribution Day 1 Student 1

Student 2

Student 3

Student 4

14.00 – 15.30 APN lectures session 2 5. Dr. Hua Wei

6. Naoi Sotaro, PhD

7. Dr. Yue Fang

15.30 – 15.45 Closing day 1 MC

Day 2: Wednesday, 20 November 2024

Time (GMT +7, Jakarta time) Agenda Speaker
08.30 – 08.45 Opening of Day 2 Symposium MC
08.45 – 10.45 APN Lectures Session 3 8. Prof. Dr. Surulivelrajan Mallayasamy, (India)

9.Prof Akhmad Kharis Nugroho

10.Dr Sabariah Noor Harun

11. Akihiro Yamada, Ph.D.

10.45 – 11.00 Break MC
11.00 – 12.30 APN Lectures Session 4 12. Prof. Muhammad Fawad Rasool (Pakistan)

13. Prof. Hwi-yeol Yun, PhD

14. Dr Siti Maisharah S Ghadzi (Malaysia)

12.30 – 13.30 Lunch Break
13.30 – 14.30 Student contribution Day 2 Student 5

Student 6

Student 7

Student 8

14.30 – 15.00 Concluding remarks of APN Symposium and workshop Prof. Kyung Soo Park

SPEAKERS LIST

A. KEYNOTE LECTURES

Presenter Name Presentation Title Institution Country
Keynote Speaker 1 Dr. Jenny Chien

Panelists:

a. Dr. Daisuke Iwata

b. Dr. Norisuke Kawai

c. Kennya Nakai

Update of ICH-15 on the strategic role of Pharmacometrics in Accelerating MIDD Ely Lilly USA USA

B. APN INVITED LECTURES

Presenter Name Presentation Title Institution Country
Invited Speaker 1 Dr. Rujia Xie MIDD to Support New Drug Applications Pharmetheus Singapore
Invited Speaker 2 Prof. Chen Zhao Progress and applications of QSP modeling in the development of new therapeutic modalities Nanjing Medical University China
Invited Speaker 3 Prof. Eun Kyoung (“Christina”) Chung, PharmD, PhD Regulatory Aspects of Integrating Pharmacometrics and Real-World Data Associate Professor of Clinical Pharmacy

Kyung Hee University

Korea
Invited Speaker 4 So Jin Lee, Pharm.D., Ph.D. Pediatric Pharmacokinetics and Dose Predictions using Pharmacometrics: A real-world example Lead of Pharmacometrics

AIMS

Korea
Invited Speaker 5 Dr. Hua Wei Integrated Modeling Approaches in the Development of Elranatamab: PMx and QSP Analyses Pfizer (China) Research & Development Center China
Invited Speaker 6 Naoi Sotaro, PhD Mechanistic Modeling in Engineered Antibody Drug Discovery and Development Research Division, Chugai Pharmabody Research, Singapore Japan
Invited Speaker 7 Dr. Yue Fang QSP application in Inflammatory Bowel Disease (IBD) Pfizer (China) Research & Development Center China
Invited Speaker 8 Prof. Dr. Surulivelrajan Mallayasamy, Predictive performance of Population pharmacokinetic models of Imatinib in Chronic Myeloid Leukemia patients Centre for Pharmacometrics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, India India
Invited Speaker 9 Prof Akhmad Kharis Nugroho Therapeutics Drug Monitoring of Meropenem Faculty of Pharmacy Unviersitas Gadjah Mada Indonesia
Invited Speaker 10 Dr Sabariah Noor Harun Pharmacokinetic Modeling of Insulin in Acute Ischemic Stroke-Induced Hyperglycemia in Patients with Concomitant Diabetes (Universiti Sains Malaysia) Malaysia
Invited Speaker 11 Akihiro Yamada, Ph.D. Case Examples for Quantitative Systems Pharmacology Modeling and Simulation Application for Drug Development New Technology, Early Development, Astellas Pharma Inc. Japan
Invited Speaker 12 Prof. Muhammad Fawad Rasool Modeling Drug Exposure in Chronic Diseases: Insights from Physiologically Based Pharmacokinetic Approaches Bahauddin Zakariya University, Multan Pakistan
Invited Speaker 13 Prof. Hwi-yeol Yun, PhD Data driven compartmental modeling by mixed effect state space model Professor of Pharmacy

Chungnam National University

Korea
Invited Speaker 14 Dr Siti Maisharah S Ghadzi Pharmacometrics modelling in clinical practice: Insights from clozapine therapy (Universiti Sains Malaysia) Malaysia

Student session

  1. Foong Keng Wah (Universiti Malaya), topic: Population Pharmacokinetics of IV Lidocaine and its Metabolites in Adult Surgical Patients
  2. Mohd. Rahimi bin Muda (Universiti Sains Malaysia and Universiti Teknologi Mara, Malaysia), topic: The impact of ABCB1 and SLCO1B1 genetic polymorphism on the pharmacokinetics of rifampicin among pulmonary tuberculosis patients: A population pharmacokinetics analysis
  3. Sohail Aziz (Universiti Sains Malaysia) Topic: Pharmacometrics Disease Progression Modelling of HbA1C among T2DM patients
  4. Yu-Ting Huang (School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan) Topic: Application of Physiologically-Based Pharmacokinetic Modeling to Digoxin Therapeutic Drug Monitoring in Renal Impairment
  5. NGUYEN Thi Cuc (National Center of Drug Information and Adverse Drug Reaction Monitoring, Hanoi University of Pharmacy) Topic: Towards optimization dosing amikacin in the treatment of Klebsiella pneumoniae infections in critically ill patients: Insights from pharmacokinetics and pharmacodynamics analyses
  6. Jared Loo Tun Fang (Universiti Sains Malaysia and Sunway Medical Centre, Malaysia), Topic: Population Pharmacokinetics Modelling of Amikacin in Neutropenic Patients with Haematological Malignancy across Different Renal Function Equations
  7. Jun Seok Cha (Department of Pharmacology, Yonsei University College of Medicine) Topic: “Quantitative Systems Pharmacology of Beclin-1’s Dual Role in Ischemic Stroke”